Lv11
40 积分 2025-12-11 加入
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
1小时前
已完结
Does siRNA therapy against ANGPTL3 bring new hope in homozygous familial hypercholesterolaemia?
1小时前
求助中
Hepatocyte-specific partial cellular reprogramming via selective OSK mRNA lipid nanoparticle attenuates liver fibrosis
4个月前
已完结
皖公网安备34019202002308
